Bright Minds Biosciences Inc (DRUG) Return on Investment ROI from the third quarter of 2026 to third quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to 0 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Bright Minds Biosciences Inc   (NASDAQ: DRUG)


Bright Minds Biosciences Inc's ROI from its third quarter of 2026 to the third quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Bright Minds Biosciences Inc's ROI in the third quarter of 2026?
Bright Minds Biosciences Inc recorded a cumulative net loss of $-19 million during 12 months ending in the third quarter of 2026, resulting in a negative return on investment (ROI) of -13.19%.

Within the Healthcare sector 305 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the second quarter of 2026 from to 4013.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2026)
III. Quarter		 (Mar 31 2026)
II. Quarter		 (Sep 30 2025)
IV. Quarter		 0
III. Quarter		 0
II. Quarter
Y / Y Investment Change TTM 323.42 % 446.01 % 1384.61 % 988.36 % 626.28 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 218 224 63 63 63
Return On Investment (TTM) -13.19 % -16.48 % -14.9 % -4.45 % -6.4 %
DRUG's Overall Ranking # 4013 # # # #
Seq. Investment Change TTM 37.7 % 64.01 % 30.38 % 43.79 % 77.58 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -19 -17 -9 -2 -2

DRUG Company Profile >> Back to DRUG Roi Comparisons >> See Annual DRUG Return On Investment



Return On Investment DRUG's Ranking
Within: No.
Industry # 108
Sector # 306
Overall # 4013

Return On Investment Statistics
High Average Low
-14.9 %
-82.18 %
-151.76 %
(Sep 30 2025)   (Sep 30 2022)



  News about Bright Minds Biosciences Inc Return on Investment ROI

Bright Minds Biosciences Seeks Redemption with $35 Million Fundraising Amidst Financial Turmoil and Competitive Pressure,

November 4, 2024

Bright Minds Biosciences: A $35 Million Gamble Amidst Dismal Financials and Industry CompetitionIn an audacious move that has raised eyebrows among investors and market analysts alike, Bright Minds Biosciences Inc. (CSE: DRUG) (NASDAQ: DRUG) has closed a non-brokered private placement, securing $35 million by selling 1,612,902 common shares at a price of $21.70 each. The announcement, made on November 4, 2024, marks a significant financial maneuver for the Vancouver-based biotech company, especially considering its recent performance and the fiercely competitive landscape it faces.This considerable influx of cash comes on the heels of the company reporting a cumulative net loss of $6 million during the 12 months leading into the fourth quarter of 2023. Coupled with a staggering negative return on investment (ROI) of -111.73%, Bright Minds finds itself ranked a concerning 4,328th in ROI within the healthcare sector—an industry where 818 companies have outperformed it. Earlier this month, on October 18, 2024, the company touted its financing as a pivotal step toward innovation, but such lofty aspirations seem daunting given its current financial performance.





Financial Statements
Bright Minds Biosciences Inc's III. Quarter Investments $ 218 Millions DRUG's Balance sheet
Bright Minds Biosciences Inc's III. Quarter Income $ -2 Millions Quarterly DRUG's Income Statement
DRUG's Income by Division See DRUG's Income by Division


DRUG Annual Return On Investment (Sep 30 2025)
2025		 (Sep 30 2024)
2024		 (Sep 30 2023)
2023		 (Sep 30 2022)
2022		 (Sep 30 2020)
2021
Total Investments in Millions 63 4 5 8 15
Y / Y Investment Growth 1423.23 % -15.32 % -36.86 % -49.94 % -
Net Income in Millions -9 -2 -5 -12 -7
Y / Y Net Income Growth - - - - -
Annual Return On Investment -14.9 % -49.89 % -112.15 % -151.76 % -44.41 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
DRUG's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for DRUG's Competitors
Subscribers only: Roi for Bright Minds Biosciences Inc's Suppliers
Subscribers only: Return On Investment for DRUG's Customers

Other Ratios
DRUG's Roa DRUG's Inventory Turnover Ratio DRUG's Growth Rates DRUG's Dividend Statistics
DRUG's Profitability Ratios DRUG's Asset Turnover Ratio DRUG's Dividend Growth
DRUG's Roe DRUG's Valuation Ratios DRUG's Financial Strength Ratios DRUG's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI

Date modified: 2026-10-03T01:41:22+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.